Cargando…
Maraviroc Failed to Control Progressive Multifocal Leukoencephalopathy-Associated IRIS in a Patient with Advanced HIV Infection
Due to the lack of therapeutic options for patients with progressive multifocal leukoencephalopathy-associated immune reconstitution inflammatory syndrome (PML-associated IRIS), maraviroc has generated expectations among the medical community. However, we report a patient with advanced HIV infection...
Autores principales: | Rodríguez, Mónica, Silva-Sánchez, Fernando Antonio, Luna-Rivero, César, Vega-Barrientos, Ricardo, Alvarado-de la Barrera, Claudia, Reyes-Terán, Gustavo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284930/ https://www.ncbi.nlm.nih.gov/pubmed/25587282 http://dx.doi.org/10.1155/2014/381480 |
Ejemplares similares
-
Progressive Multifocal Leukoencephalopathy
por: Adang, Laura, et al.
Publicado: (2015) -
Severe Progressive Multifocal Leukoencephalopathy (PML) and Spontaneous Immune Reconstitution Inflammatory Syndrome (IRIS) in an Immunocompetent Patient
por: Krey, Lea, et al.
Publicado: (2019) -
Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS
por: Hodecker, Sibylle C., et al.
Publicado: (2017) -
Treatment of progressive multifocal leukoencephalopathy
por: Castle, Daniel, et al.
Publicado: (2019) -
Progressive Multifocal Leukoencephalopathy in an Immunocompetent Patient?
por: Johansen, Krisztina K., et al.
Publicado: (2013)